Drugs · acquisition-cost intelligence
ciclopirox
· ingredient ciclopiroxOther antifungals for topical use· CICLOPIROX 10 mg/.96mL; CICLOPIROX 1 g/100mL
What this is. Acquisition-cost intelligence for pharmacy & clinic buyers — the historical trend, generic-equivalent costs, and Part D posture. NADAC is a pharmacy acquisition cost (the national average pharmacies pay), not a retail or cash price — for consumer cash prices use GoodRx/your plan.
Acquisition benchmark · NADAC per ML
$0.26404
NADAC — pharmacy acquisition cost, not a retail/cash price
Acquisition-cost history
Weekly NADAC per ML — the trend nobody else shows. 7 weeks.
2025-12-172026-05-20
Same-ingredient options by acquisition cost
Other ciclopirox products, cheapest acquisition cost first. Per ML — confirm strength/form equivalence before switching.
| Product | NADAC / ML | vs this |
|---|---|---|
| ciclopirox olamine | $0.18367 | −$0.08040 |
| Ciclopirox Olamine | $0.55004 | +$0.28600 |
| ciclopirox | $0.88316 | +$0.61910 |
| ciclopirox | $1.34 | +$1.08 |
Medicare Part D coverage · CY2026
On 223 plan formularies · typical tier 3
Prior auth 0% · Step therapy 0% · Quantity limit 57% of formularies
Sources: CMS NADAC (pharmacy acquisition cost), FDA NDC + RxNorm (identity), RxClass (therapeutic class), CMS Medicare Part D formulary (coverage). Observed reference data for professional buyers — not a retail/cash price, not pricing or medical advice. Verify before purchasing or substituting.